Successful treatment of acquired haemophilia A

被引:1
|
作者
Andrea, Kovacs [1 ]
Balazs, Tajti [1 ]
Istvan, Szoboszlay [2 ]
Zsuzsanna, Bereczky [3 ]
Peter, Ilonczai [1 ]
机构
[1] Markhot Ferenc Oktatokorhaz & Rendeloint, Belgyogyaszati Osztaly, Eger, Hungary
[2] Markhot Ferenc Oktatokorhaz & Rendeloint, Kozponti Lab, Eger, Hungary
[3] Debreceni Egyet, Altalanos Orvostud Kar, Klin Kozpont, Lab Med Int,Klin Lab Kutato Tanszek, Debrecen, Hungary
关键词
acquired haemophilia; coagulation factor; activated partial thromboplastin time; MANAGEMENT; PROPHYLAXIS; INHIBITORS; DIAGNOSIS; THERAPY;
D O I
10.1556/650.2021.32245
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acquired haemophilia A is a rare autoimmune disorder, in which antibodies are formed against coagulation factor VIII. The effect of the inhibitor on blood clotting results in severe, life-threatening bleeding diathesis. The patient's life depends on the rapid diagnosis: besides the characteristic clinical presentation, a prolonged activated partial thromboplastin time, which is not corrigible with normal plasma, suggests the existence of the disorder. In the case of the female patient who was referred to our hospital due to severe anaemia, acquired haemophilia A was diagnosed rapidly, the day after her admission. We used activated prothrombin complex concentrate to stop the bleeding, and introduced immunosuppressive therapy. The early recognition of the disease and immediate initiation of adequate treatment resulted in the patient's full recovery. With our case presentation, we would like to draw attention to the fact that the rapid diagnosis of acquired haemophilia A depends on the determination of a simple, easily accessible coagulation parameter, the activated partial thromboplastin time and on the immediate recognition of its incorrigible prolongation.
引用
收藏
页码:1977 / 1981
页数:5
相关论文
共 50 条
  • [41] Acquired Haemophilia: an Update
    Schmalzing, Marc
    AKTUELLE RHEUMATOLOGIE, 2022, 47 (06) : 502 - 505
  • [42] Management of acquired haemophilia A
    Tiede, A.
    Scharf, R. E.
    Dobbelstein, C.
    Werwitzke, S.
    HAMOSTASEOLOGIE, 2015, 35 (04): : 311 - +
  • [43] Management of acquired haemophilia A
    Collins, P. W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 226 - 235
  • [44] A child with acquired haemophilia
    Somaratne, P. D. I. S.
    Jansan, J.
    Senanayake, H. M. S.
    Ratnamalala, V.
    Jayathilake, M. M.
    Thirumavalavan, K.
    CEYLON MEDICAL JOURNAL, 2014, 59 (02) : 66 - 67
  • [45] On acquired haemophilia A in Sweden
    Lindgren, A
    Stigendal, L
    Tengborn, L
    Johnsson, H
    Berntorp, E
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS875 - PS875
  • [46] Overview of acquired haemophilia A
    Collins, P. W.
    HAEMOPHILIA, 2008, 14 : 1 - 1
  • [47] The management of acquired haemophilia
    Green, D.
    HAEMOPHILIA, 2006, 12 : 32 - 36
  • [48] Treatment of minor severe acquired haemophilia. Is there a rationale for immunoadsorption?
    Goldmann, G.
    Marquardt, N.
    Horneff, S.
    Oldenburg, J.
    Zeitler, H.
    ATHEROSCLEROSIS SUPPLEMENTS, 2015, 18 : 74 - 79
  • [49] Acquired haemophilia A in Finland: A nationwide study of incidence, treatment and outcomes
    Nummi, Vuokko
    Hiltunen, Leena
    Szanto, Timea
    Poikonen, Eira
    Lehtinen, Anna-Elina
    HAEMOPHILIA, 2024, 30 (05) : 1130 - 1137
  • [50] Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisal
    Sumner, M. J.
    Geldziler, B. D.
    Pedersen, M.
    Seremetis, S.
    HAEMOPHILIA, 2007, 13 (05) : 451 - 461